Facebook
Twitter
Telegram
Report an ErrorKura Oncology Financial Ratios 2011-2024 | KURA
Annual Financial Ratios Kura Oncology
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-10.4 | -5.9 | -8.1 | -16.6 | -7.9 | -9.1 | -12.7 | -4.0 | -2.1 | - | - | - | - |
P/S |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EPS |
-2.1 | -2.0 | -2.0 | -1.7 | -1.5 | -1.7 | -1.5 | -1.5 | -2.3 | -0.0 | -0.0 | -0.0 | -0.0 |
EV (Enterprise Value) |
1.61 B | 787 M | 990 M | 1.2 B | 495 M | 555 M | 454 M | 114 M | 37.4 M | 3.69 M | 126 K | 98.8 K | 70.5 K |
EBITDA per Share |
0.01 | 0.01 | 0.01 | - | -1.49 | -1.79 | -1.55 | -1.52 | -2.4 | - | - | - | - |
EV/EBITDA |
1670.3 | -13.9 | -7.7 | -8.6 | -12.4 | -3.8 | -1.4 | - | - | - | - | ||
PEG |
0.46 | -1.49 | 0.65 | -0.69 | -3.73 | 0.11 | -0.0 | - | - | - | - | ||
P/B |
4.0 | 1.9 | 2.1 | 2.4 | 2.3 | 3.4 | 5.6 | 2.0 | 0.6 | - | - | - | - |
P/CF |
-12.8 | -7.3 | -10.1 | -21.3 | -9.1 | -11.3 | -15.8 | -4.4 | -2.7 | - | - | - | - |
ROE % |
-38.42 | -32.32 | -25.75 | -14.67 | -28.86 | -37.55 | -44.37 | -48.46 | -27.56 | - | - | - | - |
ROA % |
-34.00 | -29.77 | -24.43 | -13.85 | -26.09 | -33.14 | -36.97 | -39.47 | -25.93 | - | - | - | - |
ROCE % |
- | - | - | - | -29.80 | -37.26 | -42.04 | -44.07 | -29.03 | - | - | - | - |
Current Ratio |
8.7 | 12.7 | 19.5 | 17.8 | 15.4 | 13.3 | 9.4 | 12.6 | 17.2 | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Kura Oncology
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.59 | - | -0.5 | -0.53 | -0.5 | - | -0.53 | -0.52 | -0.49 | - | -0.5 | -0.51 | -0.46 | - | -0.42 | -0.4 | -0.42 | -0.39 | -0.36 | -0.38 | -0.37 | -0.42 | -0.4 | -0.45 | -0.46 | - | -0.38 | -0.4 | -0.39 | - | -0.37 | -0.36 | -0.36 | - | -0.57 | -0.54 | -1.41 | -25.98 | -26.94 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | - | - | - | - | 0.01 | - | - | - | 0.01 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.01 | -2.38 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-35.85 | -25.69 | -34.15 | -33.63 | -33.28 | -23.01 | -29.26 | -27.05 | -25.34 | -17.52 | -21.41 | -19.05 | -16.37 | -10.39 | -18.55 | -22.16 | -25.63 | -28.86 | -30.69 | -32.52 | -34.85 | -37.55 | -39.24 | -41.60 | -42.24 | -30.91 | -43.09 | -43.58 | -45.50 | -35.54 | -42.96 | -38.20 | -33.29 | -19.67 | 87.26 | 96.60 | 103.60 | 109.22 | 7.24 | 10.27 | 15.52 | 15.22 | 21.52 | 22.88 | 24.01 | 18.51 | 27.73 | 30.63 | 33.96 | 26.69 | 9.21 | 9.90 | 7.58 |
ROA % |
-32.75 | -23.66 | -31.58 | -31.36 | -30.36 | -20.94 | -26.89 | -18.40 | -24.16 | -16.65 | -20.32 | -18.05 | -15.46 | -9.81 | -17.19 | -20.29 | -23.30 | -26.09 | -27.54 | -28.99 | -30.90 | -33.14 | -34.05 | -35.56 | -35.64 | -25.75 | -35.67 | -35.86 | -37.24 | -28.95 | -35.93 | -32.99 | -29.85 | -18.51 | -284.91 | -282.72 | -276.82 | -272.11 | -73.41 | -136.32 | -210.24 | -208.00 | -280.42 | -285.15 | -286.23 | -147.93 | -147.93 | -75.50 | - | - | - | - | - |
ROCE % |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.14 | 0.28 | 0.43 | 0.41 | 4.02 | 7.49 | 11.74 | 11.82 | 16.77 | 18.12 | 18.96 | 14.65 | 22.53 | 25.45 | 28.79 | 22.73 | 7.88 | 8.58 | 6.27 |
Current Ratio |
11.3 | 8.7 | 10.8 | 14.1 | 13.8 | 12.7 | 15.8 | - | 22.3 | 19.5 | 20.5 | 22.2 | 18.1 | 17.8 | 17.8 | 17.8 | 17.8 | 10.4 | 10.4 | 10.4 | 10.4 | 8.5 | 8.5 | 8.5 | 8.5 | 6.0 | 6.0 | 6.0 | 6.0 | 5.4 | 5.4 | 5.4 | 5.4 | 16.9 | 16.9 | 16.9 | 16.9 | 0.3 | 0.3 | 0.3 | 0.3 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency